fda warning letters compounded semaglutide tirzepatide 2024 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Compounded weight loss injections —
Description
We employ variants of the peptides GLP-1 and exendin-4 to explore the interplay between helical propensity near the agonist N-terminus and the ability to bind to and activate the receptor

Kisspeptin shows real promise for ovulation induction
REGISTRATION: URL: Unique identifier: NCT04847557.

Accessibility: Lilly plans Medicare pricing at $50/month starting April 2026, with self-pay options through LillyDirect ranging from $149-$399 depending on dose
